Vitamin D Deficiency Presenting as Proximal Myopathy: An Overlooked Diagnosis - A Case Series and Review of the Literature - European Medical Journal


Vitamin D Deficiency Presenting as Proximal Myopathy: An Overlooked Diagnosis – A Case Series and Review of the Literature

16 Mins
Download as | PDF
*Venkatraman Rajkumar

The author has disclosed no conflicts of interest.


All authors were involved in planning and supervising the work, processing the data, performing the analysis, drafting the manuscript, designing the figures, calculations and statistical analysis, discussing the results, and commenting on the manuscript.


Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.


The prevalence of vitamin D deficiency is ubiquitous. Severe disease can present very dramatically and can be misleading to the treating physician, resulting in mismanagement. A high index of suspicion in vulnerable patients should help circumvent this problem, including a thorough history and physical examination to lead the clinician in the right direction. Insidious onset and progressive proximal pelvic girdle myopathy, in the absence of other neurological findings, in the appropriate patient should prompt the physician to test for serum 25 hydroxyvitamin D levels.

The literature on endocrine myopathy does not highlight this condition as much as it does the thyroid, parathyroid, and adrenal aetiologies. Testing for vitamin D deficiency is simple, and treatment is available all over the world. The following article presents three patients, in different scenarios, with the condition. In all three patients, incapacitating pelvic girdle weakness resolved and quality of life improved dramatically with timely intervention. Most importantly, the correct approach prevented misdiagnosis and mismanagement.


Vitamin D is essential for skeletal and skeletal muscle health. It is present in varying quantities in certain foods, but the average diet does not contain enough to meet daily needs. A good source is exposure to sunlight for sufficient time to enable the skin to synthesise the vitamin from cholesterol using the ultraviolet spectrum. In some countries, a regulated process of fortification of certain commonly consumed foods exists.

Vitamin D deficiency is found all over the world, even in sunnier, more tropical countries.1Factors contributing to this deficiency includes poor food choices, malnutrition, malabsorption, extreme obesity, religious prohibitions mandating people to cover the bodily areas, work schedules predominantly indoors, the use of P450 enzyme-inducing medications, chronic kidney disease, and lack of awareness of the condition, even among healthcare professionals.

To identify at-risk individuals, diet analysis, sun exposure time, and investigating malabsorption states are crucial. A growing number of patients developing multiple vitamin and mineral deficiencies after bariatric surgery bypasses are a recent addition.2Timely intervention can reduce morbidity and mortality to a great extent. Furthermore, prevention of this condition is most cost-effective. Early on, clinically asymptomatic deficiency is common. As the disease progresses, bone pain, muscle aches, and muscle weakness sets in. During this phase, as a result of the non-specific nature of the symptoms, the diagnosis is often overlooked. As the condition progresses, patients may develop profound weakness in the proximal muscles of the pelvic girdle, which leads to difficulty in rising from a bed, chair, or climbing stairs. Patients may become bedridden and need multi-person assistance for their activities of daily living (ADL), compromising their quality of life. A high index of suspicion in patients presenting with pelvic girdle myopathy, in the absence of other neuromuscular findings, will lead to the correct diagnosis. This article illustrates three different case scenarios, all presenting with proximal myopathy and clinical confusion with other myopathic disorders or malignancies that can lead to disastrous consequences.


Patient One

A 60-year-old female and entrepreneur of Indian descent presented with an inability to raise herself from bed for 1 month. She had been bedridden and required the assistance of two people to perform her ADL. Her problem started 8 months earlier, with difficulty climbing stairs and became progressively worse, forcing her to shift her office to the ground level. There was no improvement after 2 months and she was finding it difficult to rise from her chair. The weakness progressed and she became bedridden. In addition, she experienced generalised pains in her muscles and bones that, at times, disturbed her sleep. Her past medical history was significant for well-controlled hypertension, while her surgical and social history were not contributory. She had natural menopause 8 years ago and is not on hormone replacement. A review of systems was not contributory. One morning, she woke up with severe pain in her right hip and presented to an orthopaedic surgeon, fearing a fracture. The orthopaedist evaluated her and ordered X-rays, finding extreme osteopenia but no fractures. She had a raised serum alkaline phosphatase and low normal calcium and phosphate. A neurologist entertained a diagnosis of myopathy. He asked for an endocrinologist to see her. The consultant noted that she had not received sunshine for almost a year. On examination, he found her to be well-nourished without pallor. Her blood pressure was well controlled. Neurological examination was significant for the severe weakness of the muscles of the hip and lower back but otherwise did not reveal any abnormalities. Th endocrinologist ordered a serum of 25 hydroxyvitamin D (25[OH]D) and intact PTH (iPTH) levels. The former was less than 1.0 ng/mL and the latter was 488.0 pg/mL. A diagnosis of secondary hyperparathyroidism due to vitamin D deficiency was evident. The patient received an intramuscular injection of vitamin D3 600,000 IU and calcium tablets of 1,000 mg elemental calcium per day. A nutritionist counselled her on increasing her dietary calcium. The patient started noticing an improvement in her strength. Gradually, she progressed to getting up from bed on her own. In 4 weeks, she walked without support into the endocrinologist’s office. Subsequently, the 25(OH)D level was 38 ng/mL and iPTH was 166 pg/mL. She continued to receive oral vitamin D 1,000 IU daily and adequate dietary calcium.

Patient Two

A 70-year-old male, a retired postal employee, presented with an inability to stand from his chair for 4 months. He was very active during employment and after retirement 10 years previous. He had no significant past medical, surgical, or social history. One year ago, his wife became bedridden. She was diagnosed with breast cancer and widespread bony metastasis. He spent most of his time indoors, caring for her. He paid little attention to himself and became very depressed when she died 6 months before presentation. His weakness prevented his self-care. He also started getting severe bone pains and muscle aches. Fearing that he had an underlying malignancy, he approached his physician. The internist diagnosed grief but, under pressure from the patient, investigated his bone pains with a nuclear bone scan. The results were shocking: multiple symmetrical hot areas throughout the entire skeleton-rule out metastasis. An oncologist evaluated the patient, found an enlarged prostate gland consistent with the patient’s age but without nodules or induration. The serum prostate specific antigen levels were within limits and no other primary cancer was evident after extensive investigations. An endocrine consultation led to the diagnosis of vitamin D deficiency (serum levels of 25(OH)D and iPTH were 2.8 ng/mL and 366.0 ng/mL, respectively). The patient received an intramuscular injection of vitamin D 600,000 IU once as well as daily calcium supplements. He also received nutritional education for increasing calcium in his diet. In 4 weeks, his weakness dramatically improved. He no longer found it difficult to get up from his chair. He ambulated without assistive devices and was able to perform all his ADL. Four months later, a repeat nuclear bone scan showed that most of the hotspots had disappeared. It reassured the treating physicians that they had progressed in the right direction. The repeat serum 25(OH) D and iPTH levels were 39 ng/mL and 144 pg/mL, respectively. He received 1,000 IU oral vitamin D daily as a maintenance dose and was encouraged to consume calcium-rich foods. After all, the patient did not have malignancy.

Patient Three

A 36-year-old female software professional, with a history of autoimmune hypothyroidism on levothyroxine 100 mcg daily presented with multiple problems. A year previously, the patient received an out-of-turn promotion for her excellent work performance and assigned to a country where food items were fortified with all vitamins and minerals. At that time, she noticed muscle aches, fatigue, migraine-like headaches, recurrent painful mouth ulcers, upper respiratory allergies, wheezing, and disturbed sleep. Soon, her menstrual periods started becoming irregular but there was no menorrhagia or clots. Her headaches became more frequent, and her respiratory complaints worsened. She became intolerant to dairy products, with abdominal bloating, cramps, and increased stool frequency. Unsteadiness upon standing with eyes open and closed followed. She started having increasing weakness in her hips and rising from her chair was an ordeal. The patient’s physician had treated her symptomatically for her ailments, without much relief. She met with several specialists, underwent many investigations, and received multiple diagnoses without avail. She presented to a new physician for a fresh look at her problems, who found her adequately nourished without pallor or clinically euthyroid, but significantly anxious and depressed. Neurological examination was positive for the weakness of the muscles of the hip and lower back and mild ataxia. The new physician reviewed her latest test results and found a normal serum thyroid-stimulating hormone level, an elevated red cell distribution width in her haemogram, and a high alkaline phosphatase but normal transaminases. He ordered iron studies and 25(OH) D. The results were consistent with non-anaemic iron deficiency (low iron, high iron-binding capacity, and decreased iron saturation but with normal haemoglobin) and secondary hyperparathyroidism due to vitamin D deficiency (25[OH]D: 8.8 ng/mL; iPTH: 266 pg/mL). The deficiencies of iron and vitamin D, with an adequate diet with fortified foods, pointed to gastrointestinal malabsorption. This, in addition to the multiorgan symptomatology, was suggestive of adult coeliac disease. The patient tested positive for serum IgA anti-transglutaminase antibodies, with normal total IgA levels. Since the patient declined an endoscopic duodenal or jejunal mucosal biopsy, histological confirmation was not possible. However, she agreed to try a gluten-free diet. She received oral iron and vitamin D (600,000 IU orally once weekly for eight weeks as initial treatment) and oral calcium supplements. The inability to tolerate dairy products was overcome by adding lactic acid bacillus tablets with each exchange of dairy.

In 4 weeks, she was able to get up from the chair without difficulty and most of her other complaints abated and she resumed her work without interruption On follow-up, she required 4,000 IU of vitamin D daily to maintain serum 25(OH)D (34 ng/mL) and iPTH levels (41 pg/mL) in the normal range.


Methods of Obtaining Vitamin D

The Vitamin D is available to the body from two sources. They are the skin and the gastrointestinal tract.

The skin

The skin has the machinery to synthesise vitamin D from cholesterol using the ultraviolet (UV) spectrum (UV: 290–315 nm wavelength) of sunlight. The ideal time for sun exposure is midday, when the maximum absorption of UV rays occurs. It is true not only in temperate zones but also in the tropics. The minimal erythemal dose to produce sufficient vitamin D synthesis will depend on the total area and time of skin exposed.3Excess vitamin D synthesised in the skin is metabolised to inactive compounds. Hence, toxicity never occurs by overexposure to sunlight.

(Table 1) lists impediments to vitamin D synthesis in the skin.

Table 1: Impediments to vitamin D synthesis in the skin.
UV: ultraviolet.

The gastrointestinal tract

Some foods, like eggs and fatty fish, contain vitamin D. The liver contains large amounts. However, the average human diet does not meet the daily requirements of vitamin D. Hence, if sunlight exposure is not adequate, supplementation is necessary. It is especially true for vulnerable groups (Table 2). Patients who have had bariatric bypass surgery will require a much higher dose of oral supplemental vitamin D. Absorption occurs in the duodenum and upper jejunum. It is protein-mediated at low concentrations as in the diet, and by unregulated passive diffusion at higher concentrations as in pharmacologic dosing.4

Table 2: Vulnerable groups for vitamin D deficiency.
CKD: chronic kidney disease.

Metabolism of Vitamin D

Both sources of vitamin D are bound to the vitamin D binding protein and is transported to the liver. The next step is 25 hydroxylation in the liver. The final step is 1 hydroxylation in the proximal tubular cells of the kidney. The resultant 1,25 dihydroxy vitamin D (1,25[OH]2D) is an active hormone that binds to the vitamin D receptors (VDR) in many tissues and exerts its actions. Unfortunately, 24 hydroxylation leads to inactivation of both 25(OH)D and 1,25(OH)2D. The formation of 1,25(OH)2D is catalysed by the enzyme 1-alphahydroxylase, enhanced by PTH. Older adults have decreased 1-alphahydroxylase activity due to diminished renal mass. In the intestinal epithelium, 1,25(OH)2D binds to VDRs and increases calcium-binding protein synthesis, which aids calcium absorption.

Latest Research Revealed

Adequate vitamin D maintains the (VDR) density in skeletal muscles and, thereby, the number and function of Type 2 fast-twitching skeletal muscle fibres. In addition, through genomic and non-genomic mechanisms, it reduces both inflammatory cytokine induced skeletal muscle damage and intramuscular adiposity by preferential differentiation of common stem cells into myoblasts instead of adipocytes. Therefore, deficiency of vitamin D results is muscle weakness and decreased reaction speed and strength to sudden postural changes and falls are the result. Recent evidence implicates a role of vitamin D in skeletal muscle repair and regeneration.5,6

Double Jeopardy in Older Adults

Older adults are particularly prone to the ill effects of vitamin D deficiency, due to poor synthesis in the skin, diminished 1-alphahydroxylase activity, and resistance to the action of 1,25(OH)2D in the intestines. A low bone mass and skeletal muscle weakness of ageing are worsened by a concomitant vitamin D deficiency. Studies of treatment in institutionalised older adults with severe vitamin D deficiency have conclusively shown a reduced incidence of falls and fractures.

Clinical Course of Vitamin D Deficiency

Mild deficiency may be asymptomatic. The deficiency is overlooked initially due to the non-specific nature of the symptoms. As the disease progresses, patients may complain of symptoms like muscle pains, fatigue, and weakness. Bone pains occur due to osteomalacia. Later on, severe muscular weakness is a hallmark condition, with a predilection to the proximal musculature of the hip region. The reason for this is unclear. The ensuing weakness may lead to falls and fractures, or the patient may become immobile due to muscle weakness as mentioned earlier. Severe localised pain in one or more bones may be due to an incomplete fracture identified on X-rays as Looser’s zones.

The clinical course in context

See (Table 3) for a comparison of the clinical characteristics of the three patients.

Table 3: Comparison of the clinical characteristics of three patients with severe vitamin D deficiency.
*Normal range for serum alkaline phosphatase: 50–150 U/L.
†Normal range for iPTH: 10–65 pg/mL.
25(OH)D: 25 hydroxyvitamin D; ALT: alanine transaminase; AST: aspartate aminotransferase; IM: intramuscular; iPTH: intact parathyroid hormone.

Whenever a patient presents with proximal myopathy, it is imperative to consider many conditions in the differential diagnosis. This is dictated by the clinical presentations. The age at initial presentation did not favour hereditary myopathies. The absence of drugs such as statins, corticosteroids, and retroviral drugs excluded drug-induced myopathy. Clinical features suggesting exposure to infective agents or toxins were also absent in all three patients. Also, features of connective tissue diseases like systemic lupus erythematosus, dermatomyositis or polymyositis, and inclusion body myositis were absent in all three patients. An extensive search did not reveal a malignancy in Patient Two. Clinically there were no suggestions of hypo- and hyperthyroidism, Cushing’s disease, or acromegaly to pursue these conditions by appropriate investigations. Conditions that caused both proximal and distal myopathies, either simultaneously or sequentially, were also excluded as only the hip muscles were affected. For similar reasons, diseases causing oculofacial and pharyngeal musculature and conditions, causing combined motor and sensory pathologies, were not entertained.

All three patients did not have pre-treatment sun exposure and severe muscle weakness was a feature in all of them. This led to misdiagnosis as myopathy in the first patient who also had features of bone loss on X-rays.

Bone pain does not warrant a bone scan

Indiscriminate use of a nuclear bone scan to investigate bone pains can lead to the erroneous diagnosis of metastatic malignancy, as noticed in Patient Two. The hotspots observed were areas of bone lysis by the elevated PTH of secondary hyperparathyroidism that disappeared after treatment, which was confirmed by a subsequent scan.

Think adult coeliac disease

The third patient had a complex presentation, challenging even the most astute clinician. Features of a multi-system involvement, predominantly outside the gastrointestinal system, have been described in adult atypical coeliac disease. This patient had a history of autoimmune hypothyroidism, which has known associations with coeliac disease. In addition, biochemical evidence of iron deficiency in the absence of blood loss, along with vitamin D deficiency despite consuming fortified foods strengthened the probability of adult atypical coeliac disease in this patient. For a detailed description of adult coeliac disease, the reader is directed to the cited reference.7 This young patient also had a secondary lactose intolerance that responded to lactic acid bacillus given orally. It supplies the deficient galactosidase enzyme to aid in lactose digestion and allows the patient to tolerate dairy products with the benefit of obtaining natural calcium.

Bariatric surgical patients: a special group

Vitamin D deficiency is an established complication of obesity and its treatment, namely bariatric surgery. The induced malabsorption may require a high maintenance dose of vitamin D and this may not be cost-effective during long-term therapy.8 However, the Endocrine Society guidelines only mention the oral formulation.

Parenteral vitamin D: some food for thought

Intramuscular (IM) injections of vitamin D are an alternative when very high oral doses are required to maintain the 25(OH)D within the normal range. There are minimal or no side effects but paucity of adequate data to exclude complications such as hypercalciuria indicate that randomised controlled trials are needed to support or refute IM vitamin D for treatment. A small study from Australia reported the safety of IM vitamin D.9 The first two patients described received injections as initial treatment because high dose oral preparations were locally unavailable at that time. Subsequently, they received smaller oral maintenance doses and responded well. The third patient presented when high-dose oral formulations became available and, although suffering from malabsorption, responded well albeit needing a higher dose.

Dosing regimen

Another issue is whether to choose a daily, weekly, or once monthly regimen for maintenance. All three regimens are effective and, the choice depends on patient characteristics (compliance issues) and provider preferences.10

Vitamin D2 or D3? What is the difference?

Two formulations of vitamin D are available. Vitamin D2 (ergocalciferol) is from plants and Vitamin D3 (cholecalciferol) is from animal sources. Again, the choice of which compound to use will depend on patient preferences (whether they are vegan or vegetarian) or provider choices. The Endocrine Society considers them equipotential but some assays of 25(OH)D may underestimate levels when treating with vitamin D2 and may complicate management.11

Follow-up testing

Serum 25(OH)D normalised in all three patients but iPTH normalised only in Patient Three. The normalisation of iPTH may happen later (sometimes after one or two years). The reasons behind this are not clear.

The practitioner should be cautious and not to increase the Vitamin D dose based on the iPTH level. Instead, they should use the 25(OH)D to guide replacement therapy. The Endocrine Society recommends a minimum level of 25(OH)D of 30 ng/mL. A level between 20 and 30 is considered insufficient, while those below 20 as deficienct.12

Will the patient get vitamin D toxicity?

If guidelines are adhered to strictly, toxicity from vitamin D is rare. Caution should be the rule when treating certain patients with chronic granulomatous diseases and certain lymphomas, which produce 1-alphahydroxylase in their macrophages and consequently increase the production of 1,25(OH)2D in an unregulated manner.13


Vitamin D deficiency is not a diagnosis of exclusion. A good history, physical examination, and relevant laboratory tests will lead to a timely diagnosis and appropriate therapy. Prevention saves healthcare costs and reduces morbidity and mortality. High-risk groups will need greater attention and will benefit most from intervention. Proximal muscle pelvic girdle myopathy in the correct context should prompt testing for 25(OH)D levels utilising reliable assays, which is the ideal substance in the blood that reflects body vitamin D stores. Testing for 1,25(OH)2D is not useful as its half life is short; does not reflect body stores of vitamin D; and is often normal, even in severe deficiency states. Unnecessary investigations like nuclear bone scans can be very misleading and should be discouraged. Treatment is readily available, safe, and effective, even when the disease is advanced. A full recovery is a rule, as seen in the above examples. Finally, it is vital to educate not only the general public but also healthcare professionals, both generalists and specialists, to enable them to recognise vitamin D deficiency in a timely manner and manage patients appropriately to improve healthcare outcomes.

Harinarayan V et al. Vitamin D status and sun exposure in India. Dermatoendocrinol. 2013;5(1):130-41. Fox A et al. Vitamin D status after gastric bypass or sleeve gastrectomy over 4 years of follow-up. Obes Surg. 2020;30(4):1473-81. Holick MF. Vitamin D: a d-lightful solution for health. J Investig Med. 2011;59(6):872-80. Maurya VK, Aggarwal M. Factors influencing the absorption of vitamin D in GIT: an overview. J Food Sci Technol. 2017;54(12):3753-65. Latham CM et al. Vitamin D promotes skeletal muscle regeneration and mitochondrial health. Front Physiol. 2021;12:660498. Sanders KM et al. Vitamin D deficiency and its role in muscle-bone interactions in the elderly. Curr Osteoporos Rep. 2014;12(1):74-81. Nunes G et al. Adult coeliac disease: the importance of extraintestinal manifestations. GE Port J Gastroenterol. 2017;24(6):292. Chakhtoura MT et al. Guidelines on vitamin D replacement in bariatric surgery: Identification and systematic appraisal. Metabolism. 2016;65(4):586-97. Gorman S et al. High-dose intramuscular vitamin D provides long-lasting moderate increases in serum 25-hydroxvitamin D levels and shorter-term changes in plasma calcium. J AOAC Int. 2017;100(5):1337-44. De Niet S et al. A randomised study to compare a monthly to a daily administration of vitamin D3 supplementation. Nutrients. 2018;10(6):659. Kennel KA et al. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc. 2010;85(8):752-8. Holick MF et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. Sarathi V et al. High-dose vitamin D supplementation precipitating hypercalcemic crisis in granulomatous disorders. Indian J Endocrinol Metab. 2017;21(6):815-9.